Cargando…
The application of exosomes in the treatment of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a heterogeneous and invasive breast cancer (BC) subtype that is estrogen receptor-negative, progesterone receptor-negative, and human epidermal growth factor receptor 2 (Her2)-negative. So far, the treatment of TNBC is still ineffective due to the lack of well...
Autores principales: | Weaver, John W., Zhang, Jinyu, Rojas, Juan, Musich, Phillip R., Yao, Zhiqiang, Jiang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684310/ https://www.ncbi.nlm.nih.gov/pubmed/36438660 http://dx.doi.org/10.3389/fmolb.2022.1022725 |
Ejemplares similares
-
DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells
por: Ogbu, Stella C., et al.
Publicado: (2021) -
Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses
por: Green-Tripp, Gabriela, et al.
Publicado: (2022) -
Machine learning-driven exploration of drug therapies for triple-negative breast cancer treatment
por: Kaushik, Aman Chandra, et al.
Publicado: (2023) -
Evaluation of NTRK Gene Fusion by Five Different Platforms in Triple-Negative Breast Carcinoma
por: Wu, Shafei, et al.
Publicado: (2021) -
Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities
por: Ribeiro, Rita, et al.
Publicado: (2022)